Monday, October 15, 2012

European private equity firm, Cinven acquires Amdipharm

Amdipharm is a family-owned international niche pharmaceuticals business. Cinven acquired Amidpharm group for a total consideration of £367 million ($589.5 million).


Initially Amdipharm will operate as a standalone business but, over time, Cinven will look to merge Amdipharm with its existing portfolio company, Mercury Pharma, which it acquired in September 2012.  Mercury and Amidpharm have complementary presence. Mercury’s customer base is largely UK focused, whereas Amdipharm has a significantly greater international business, with its products sold in over 80 countries worldwide.

Amdipharm was founded by Vijay and Bhikhu Patel. The Group, which has grown strongly through acquisition, today generates revenues of over £110 million.Amidpharm is valued at 3.5 times revenue.